(CBT) Cabot - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1270551013

CBT: Specialty Chemicals, Performance Materials

Cabot Corporation (NYSE:CBT) is a global leader in specialty chemicals and performance materials, operating through two core segments: Reinforcement Materials and Performance Chemicals. The company specializes in advanced materials solutions for industrial and consumer applications. Its product portfolio includes reinforcing carbons, engineered elastomer composites, specialty carbons, fumed silica, fumed alumina, aerogel, masterbatch and conductive compounds, inkjet colorants, carbon nanotubes, and fumed metal oxides. These materials are integral to a wide range of industries, including automotive, electronics, energy storage, construction, cosmetics, and consumer goods. Cabots products enhance performance, durability, and efficiency in applications such as tires, batteries, adhesives, coatings, and thermal insulation. With a global distribution network spanning the Americas, Europe, the Middle East, Africa, and Asia Pacific, the company serves a diverse customer base. Founded in 1882 and headquartered in Boston, Massachusetts, Cabot Corporation has established itself as a key player in the specialty chemicals sector.

Based on the provided and , Cabot Corporations stock (NYSE:CBT) is expected to remain range-bound over the next three months, with potential resistance at the SMA 50 level of 82.37 and support near the SMA 200 level of 95.89. The stock is currently trading slightly below its SMA 20 (79.42) and SMA 50 (82.37), indicating near-term consolidation. The ATR of 2.97 suggests moderate volatility. From a fundamental perspective, the companys P/E ratio of 10.55 and forward P/E of 10.49 indicate stable earnings expectations. The P/B ratio of 3.15 and P/S ratio of 1.08 reflect a premium valuation, while the RoE of 30.97 highlights strong profitability. Overall, the stock is likely to trade in a narrow range, with upside limited by technical resistance and downside supported by solid fundamentals.

Additional Sources for CBT Stock

CBT Stock Overview

Market Cap in USD 4,229m
Sector Basic Materials
Industry Specialty Chemicals
GiC Sub-Industry Commodity Chemicals
IPO / Inception 1980-11-05

CBT Stock Ratings

Growth Rating 57.9
Fundamental 72.2
Dividend Rating 61.0
Rel. Strength -21.1
Analysts 3.6/5
Fair Price Momentum 72.62 USD
Fair Price DCF 176.81 USD

CBT Dividends

Dividend Yield 12m 2.02%
Yield on Cost 5y 6.06%
Annual Growth 5y 3.84%
Payout Consistency 89.5%

CBT Growth Ratios

Growth Correlation 3m -87.6%
Growth Correlation 12m -57.4%
Growth Correlation 5y 93.8%
CAGR 5y 21.22%
CAGR/Max DD 5y 0.57
Sharpe Ratio 12m -1.80
Alpha -35.11
Beta 0.887
Volatility 47.29%
Current Volume 680.8k
Average Volume 20d 425.4k
What is the price of CBT stocks?
As of May 09, 2025, the stock is trading at USD 74.31 with a total of 680,826 shares traded.
Over the past week, the price has changed by -3.77%, over one month by -0.66%, over three months by -13.49% and over the past year by -25.19%.
Is Cabot a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Cabot (NYSE:CBT) is currently (May 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 72.15 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CBT as of May 2025 is 72.62. This means that CBT is currently overvalued and has a potential downside of -2.27%.
Is CBT a buy, sell or hold?
Cabot has received a consensus analysts rating of 3.60. Therefor, it is recommend to hold CBT.
  • Strong Buy: 2
  • Buy: 0
  • Hold: 2
  • Sell: 1
  • Strong Sell: 0
What are the forecast for CBT stock price target?
According to ValueRays Forecast Model, CBT Cabot will be worth about 80.2 in May 2026. The stock is currently trading at 74.31. This means that the stock has a potential upside of +7.87%.
Issuer Forecast Upside
Wallstreet Target Price 91 22.5%
Analysts Target Price 111 49.4%
ValueRay Target Price 80.2 7.9%